syneos health in the news
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Our daily ratings and market update email newsletter. Type a symbol or company name. Thats down from the 1.29 it ended Q2 with and below the 1.20 threshold that the company would have to regularly maintain in order to deliver on its 2023 clinical growth profile. Reuters, the news and media division of Thomson Reuters, is the worlds largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers. Upon completion, Syneos Health will become a private company, and the shares of SYNHs Class A common stock will no longer trade on the Nasdaq. Syneos Health (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. The institutional investor owned 2,475 shares of the companys stock after buying an additional 1,926 shares during the period. The firm has a market cap of $4.31 billion, a price-to-earnings ratio of 29.06 and a beta of 1.61. MORRISVILLE, N.C., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that, effective March. Newsroom. The Company expects to maintain its headquarters in Morrisville, North Carolina. Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Zscaler: Analysts Raise the Bar for the AI Cloud Security Company, Syneos Health (NASDAQ:SYNH) Now Covered by Analysts at StockNews.com, PNC Financial Services Group Inc. Sells 6,833 Shares of Syneos Health, Inc. (NASDAQ:SYNH), Cornercap Investment Counsel Inc. Has $939,000 Stake in Syneos Health, Inc. (NASDAQ:SYNH), Research Analysts Issue Forecasts for Syneos Health, Inc.'s Q2 2023 Earnings (NASDAQ:SYNH), HRT Financial LP Sells 28,070 Shares of Syneos Health, Inc. (NASDAQ:SYNH), Syneos Health, Inc. Expected to Post Q2 2023 Earnings of $0.60 Per Share (NASDAQ:SYNH), Syneos Health (NASDAQ:SYNH) Coverage Initiated by Analysts at StockNews.com, FivepHusion team up with Treehill Partners and Syneos Health, GW&K Investment Management LLC Sells 810,994 Shares of Syneos Health, Inc. (NASDAQ:SYNH), Syneos Health (NASDAQ:SYNH) Earns Hold Rating from Analysts at StockNews.com, Prescott Group Capital Management L.L.C. However, the company expects to maintain its headquarters in Morrisville, NC. Copyright As a result of COVID-19, pharma marketing will never be the same. The Syneos Health Board of Directors is giving its unanimous support to the deal. MORRISVILLE, N.C., April 13, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), a leading fully . MORRISVILLE, N.C., April 04, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced Jeanine OKane as President of Syneos Health Communications a portfolio of agencies spanning advertising, public relations, Program Drives Digital and Omnichannel Engagement for Medical Science Liaison Teams & Medical Conferences MORRISVILLE, N.C., March 27, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the launch of Medical, Collaboration Will Leverage Data Analytics and AI to Accelerate Clinical Trial Execution MORRISVILLE, N.C., March 22, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with KX, maker, Collaboration Leverages AI-ready Technology to Speed Asset Development and Optimize Performance MORRISVILLE, N.C., March 20, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic multi-year agreement, Newly Established Network Will Enable High Quality DCTs & DigitalHealth Technology Solutions MORRISVILLE, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the launch of a Decentralized, Revenue for the fourth quarter of $1,359.9 million decreased 1.0% on a reported basis and increased 1.7% on a constant currency basis year-over-year. Citing the pending transaction, SYNH did not provide its financial outlook for 2023. Feb 27 (Reuters) - Syneos Health Inc (SYNH.O) is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug developers led to a 52% plunge. SYNH stock is gaining on acquisition news. 2023 Syneos Health. Why Is Babylon (BBLN) Stock Down 57% Today? You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. A group of investors led by Elliott Investment Management intend to. Access this report to discover which battery stocks to buy and which to avoid. Estimates for SiBones 2023 loss per share have narrowed down from $1.63 to $1.61 in the past 30 days and $1.44 in the past 7 days. The company is also experiencing delays in large pharma award decisions, with net awards being impacted by greater-than-normal delays. Collectively, this slower pace of new awards now has SYNH anticipating its clinical trailing 12-month book-to-bill ratio at the end of Q3 to be in the range of 1.05-1.15 (excluding reimbursable costs). Articles below include archived media coverage from both INC Research and inVentiv Health. View which stocks are hot on social media with MarketBeat's trending stocks report. It also has the companys stock rising 8.7% as of Wednesday morning. And unfortunately for Syneos Health, Inc. ( NASDAQ:SYNH) shareholders,. Todays news also brings heavy trading to SYNH stock with some 3.8 million shares on the move. ET. Once cooler heads prevail, we expect shares of SYNH to begin recovering in kind. Want to see what other hedge funds are holding SYNH? Stock chart is not supported by your current browser Gain. If you have an ad-blocker enabled you may be blocked from proceeding. Per a representative of Syneos Healths management, the merger will enable the company to accelerate its growth strategy, enhance customer delivery and evolve the organization toward a tech-enabled future. Finally, Connor Clark & Lunn Investment Management Ltd. grew its holdings in shares of Syneos Health by 4,702.8% in the fourth quarter. You have already added five stocks to your watchlist. Real-time analyst ratings, insider transactions, earnings data, and more. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers delivery of important therapies to patients. Based in Morrisville, North Carolina, Syneos helps pharmaceutical companies with clinical trials and to market their drugs. All rights reserved. Syneos Health (NASDAQ:SYNH) stock is on the rise Wednesday as investors react to news of a $7.1 billion acquisition deal. Articles below include archived media coverage from both INC Research and inVentiv Health. MORRISVILLE, N.C., May 16, 2023 (GLOBE NEWSWIRE) Syneos Health ( Nasdaq:SYNH ), a leading fully integrated biopharmaceutical solutions organization, today announced PM360 has named Maria Fotiu, President, Sites and Patients, Syneos Health; Sayee Natarajan, CEO & Co-founder, RxDataScience (a Syneos Health company); and Greg Christie, Chief Pr. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. The news of the merger was declared simultaneously on the day of Syneos Health's first quarter 2023 earnings release. In the last reported quarter, Accelerate Diagnostics delivered an earnings surprise of 12.50%. John Dineen, chairman of Syneos Health, said this about the deal sending SYNH stock higher today. 326 E 8th St #105, Sioux Falls, SD 57103 We support a diverse, equitable and inclusive culture. Earnings estimates for Penumbra have increased from $1.25 to $1.47 in 2023 and $2.33 to $2.51 in 2024 in the past 30 days. In the past six months, shares of Syneos Health have increased 21.8% compared with the industrys rise of 54%. See here for a complete list of exchanges and delays. 1125 N. Charles St, Baltimore, MD 21201. As many companies are cutting funding due to an economic downturn, Syneos Health is having trouble finding revenue sources. In real life you can have the elements you have chosen. Stock market today: Asian stocks follow Wall St up after strong US jobs report. Syneos, which carries a debt pile of nearly $3 billion, was created in 2017 by INC Research Holdings Inc's acquisition of inVentiv Health Inc for $7.4 billion, including debt. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. News Releases In The News Media Contact From Date: Select date To Date: Select date Apply Makes New $2.03 Million Investment in Syneos Health, Inc. (NASDAQ:SYNH), Syneos Health Appoints Batisha Anson to Global Head, Patient Diversity and Health Equity, Syneos Health Appoints Batisha Anson to Global Head,Patient Diversity and Health Equity, Clearbridge Investments LLC Decreases Holdings in Syneos Health, Inc. (NASDAQ:SYNH), Thrivent Financial for Lutherans Has $2.16 Million Holdings in Syneos Health, Inc. (NASDAQ:SYNH), Mizuho Raises Syneos Health (NASDAQ:SYNH) Price Target to $43.00, Syneos Health (NASDAQ:SYNH) Sees Strong Trading Volume Following Analyst Upgrade, Bank of Nova Scotia Purchases New Shares in Syneos Health, Inc. (NASDAQ:SYNH), Syneos Health, Inc. (NASDAQ:SYNH) Given Average Rating of "Hold" by Brokerages, Mizuho Maintains Syneos Health Inc - (SYNH) Neutral Recommendation, 8 Analysts Have This to Say About Syneos Health, Syneos Health Leaders Recognized as PM360 2023 ELITE Award Recipients, Syneos Health (NASDAQ:SYNH) Downgraded by Robert W. Baird to "Neutral", Syneos Health (NASDAQ:SYNH) Sees Large Volume Increase, Investment firms to take North Carolina health-care giant Syneos private in $7.1B deal, Syneos Health (NASDAQ:SYNH) Shares Gap Up to $38.45, Syneos Health (NASDAQ:SYNH) Lowered to "Hold" at Deutsche Bank Aktiengesellschaft, Syneos Health, Inc. (NASDAQ:SYNH) Receives Average Recommendation of "Hold" from Brokerages, Barclays Upgrades Syneos Health (NASDAQ:SYNH) to Equal Weight, Barclays Upgrades Syneos Health Inc - (SYNH), SHAREHOLDER ALERT: Rigrodsky Law, P.A. . MarketBeat.com's FREE daily email newsletter, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Sells 907 Shares of NovoCure Limited. Citing the pending transaction, SYNH did not provide its financial outlook . This slide was driven by an operational update provided during an investor presentation at the Baird Global Healthcare Conference earlier today. Constellation Brands Taps into Growth: Analysts Bullish on Stock, CrowdStrike: Another Tech Stock to Buy on the Dip. All Rights Reserved, Biostatistics and Statistical Programming, Scientific and Medical Affairs Advisory Group, Standard contractual clauses for suppliers. The digital asset underscores SYNHs continued focus on Medical Affairs to ensure that its customers and clinicians have access to the latest education to optimize patient outcomes. [email protected] Have a question for our media relations team? The news of the merger was declared simultaneously on the day of Syneos Healths first quarter 2023 earnings release. In the same month, Syneos Health entered into a strategic partnership with KX, the maker of kdb, the worlds fastest time series database and analytics engine. Syneos Health (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. Earlier in March 2023, Syneos Health announced the launch of the Medical Affairs Digital Amplifier, which is designed to drive smarter and more effective scientific exchange. Connor Clark & Lunn Investment Management Ltd. now owns 380,476 shares of the companys stock valued at $13,956,000 after acquiring an additional 372,554 shares in the last quarter. Zacks->. Syneos Health was created in August 2017, when INC Research and inVentiv Health merged to create the only fully-integrated biopharmaceutical solutions organization. Get short term trading ideas from the MarketBeat Idea Engine. The Company has a strong operating foundation, differentiated, integrated solutions and a focus on being committed to customers. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of . That said, SYNHs stock had taken a pounding after initially revealing these softening order trends when it reported Q2 earnings early last month and was already down 38% for the year. The Morrisville-based contract research . Shares of the company have increased 10.2% in the past year compared with the industrys rise of 9.1%. This is majorly denting SYNHs business growth. It operates through the Clinical Solutions and Commercial Solutions segments. It includes interests from multiple parties, backed by the assistance of independent financial and legal advisors. Penumbras stock has risen 134.8% in the past year. Syneos Health is expecting the acquisition deal to close in the second half of 2023. Bloomberg News first reported the news of the investment consortium's talks with Syneos. We support a diverse, equitable and inclusive culture. The consortium of private investment firm affiliates includes Elliott Investment Management, Patient Square Capital and Veritas Capital. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. NASDAQ:SYNH opened at $41.56 on Monday. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Sells 7,940 Shares of Sirius XM Holdings Inc. (844) 978-6257. We support a diverse, equitable and inclusive culture. Is Investigating Syneos Health, Inc. Anirban rejoined Reuters in 2019 as Editor in Charge, Finance to lead a team of reporters, covering everything from investment banking to venture capital. The analysis comes after after a Monday report that the contract . Among them is what has shares of SeaStar Medical(NASDAQ:ICU), Babylon(NYSE:BBLN), and CTI BioPharma(NASDAQ:CTIC) stock moving today. Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology. Many of these clients have cut spending as they have found it difficult to raise funding in a post-COVID-19 market downturn. All Rights Reserved. These symbols will be available throughout the site during your session. Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. Please. Why Is CTI BioPharma (CTIC) Stock Up 85% Today? Canadian Western Bank (TSE:CWB) Raises Dividend to $0.33 Per Share, Quadrant Capital Group LLC Grows Stock Holdings in Genuine Parts (NYSE:GPC), Get a free copy of the StockNews.com research report on Syneos Health (SYNH). Taesik Yoon is the editor of Forbes Investor. The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. PENs earnings beat estimates in all the past four quarters, delivering an average surprise of 109.42%. Completion of the transaction is expected in the second half of 2023, subject to the approval of Syneos Health shareholders and the satisfaction of other customary closing conditions, including regulatory approvals. Given our belief that this had more than priced in the expectations for such slower growth ahead and that the healthy pipeline of clinical opportunities longer out within both the large pharmaceutical and SMID markets remains supportive of a return to the stronger growth trends the company had been enjoying prior to 2022 once customer decision-making activity normalizes, we view todays steep additional slide as unwarranted and clearly exacerbated by what was one of the worst days for the U.S. equity market ever. In The News. Assenagon Asset Management S.A. now owns 1,056,150 shares of the companys stock valued at $38,740,000 after buying an additional 558,694 shares during the last quarter. 3 min read The nature of investing is that you win some, and you lose some. Singapore-listed utilities firm Sembcorp Industries Ltd said on Monday its unit has signed a deal worth S$1.9 billion ($1.41 billion) with a subsidiary of PT Medco Energi Internasional to import natural gas from Indonesia. In the last reported quarter, it posted an earnings surprise of 109.09%. On the date of publication, William Whitedid not have (either directly or indirectly) any positions in the securities mentioned in this article. To read this article on Zacks.com click here. Upon completion of the transaction, Syneos Health will become a private company and shares of Syneos Health Class A common stock will no longer trade on the Nasdaq. Buyout, Shareholder Alert: Ademi LLP investigates whether Syneos Health, Inc. has obtained a Fair Price in its transaction with the Investment Consortium, SYNH STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Syneos Health, Inc. Is Fair to Shareholders, Robert W. Baird downgrades Syneos Health (SYNH) to a Hold, Investment firms to take Syneos private in $7B deal. Syneos Health currently carries a Zacks Rank #3 (Hold). An awful day for the stock market turned into a terrible one for shares of Syneos Health (SYNH), which fell 13.7%. May 10 (Reuters) - An investment consortium, comprising of Elliott Investment Management, Patient Square Capital and Veritas Capital, has agreed to take Syneos Health Inc (SYNH.O) private for. That represents a 24% premium to the unaffected closing price of SYNH stock as of Feb. 13, 2023. After starting with Reuters in Bangalore in 2009, Anirban left in 2013 to work as a technology deals reporter in several leading business news outlets in India, including The Economic Times and Mint. Syneos Health Appoints Batisha Anson to Global Head,Patient Diversity and Health Equity, Syneos Health Leaders Recognized as PM360 2023 ELITE Award Recipients, Syneos Health Reports First Quarter 2023 Results, Syneos Health Appoints Michael Bonello asChief Financial Officer, Syneos Health Names Jeanine OKane asCommunications President, Syneos Health Launches Medical Affairs Digital Amplifier, Syneos Health and KX Partner to Pioneer Data-Driven Transformation in Biopharmaceutical Asset Development, Syneos Health Collaborates with Microsoft to Accelerate AI Across the Clinical to Commercial Continuum, Syneos Health Unveils New Decentralized ClinicalTrial Site Network to Drive DCT Adoption, Syneos Health Reports Fourth Quarter and Full Year 2022 Results, Syneos Health Schedules Fourth Quarter and Full Year 2022 Earnings Call for Thursday, February 16th, 2023, Syneos Health Partners with Equicare, Optimizing Data Capture and Integration to Accelerate Clinical Trial Research, Syneos Health and Haystack Health Partner to Accelerate Clinical Trials with AI, Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies, Syneos Health Partners with Clinical Research Malaysia, Expanding Catalyst Site Network Partnership to Malaysia, Syneos Health Announces Partnership with Fosun Pharma USA to Launch Serplulimab, Syneos Health Dealmakers Intentions Survey Sees Optimism for M&A and Licensing Deals in 2023, Syneos Health Announces Chief Financial Officer Transition, Syneos Health to Present at the 41st Annual J.P. Morgan Healthcare Conference, Standard contractual clauses for suppliers. Market open. Learn about the media coverage comparison. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of . Together we share insights, use the latest technologies and apply advanced business practices to speed our customers delivery of important therapies to patients. This No-Name Street in San Francisco Is the Birthplace of the Next Big Megatrend, Louis Navellier and the InvestorPlace Research Staff, Miracle Psychedelics Could Save Lives and Mint Millions, Dear MULN Stock Fans, Mark Your Calendars for June 26, Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday, NIO Stock Alert: China Just Gave Nio a Big Boost. Mallinckrodt Plc said on Monday it was considering a second bankruptcy filing and other options after its lenders raised concerns over an upcoming $200 million payment related to opioid-related litigation. This has them paying $7.1 billion to acquire the company. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Sign up to receive the latest news and ratings for SYNH and its competitors with MarketBeat's FREE daily newsletter. Syneos Health was created in August 2017, when INC Research and inVentiv Health merged to create the only fully-integrated biopharmaceutical solutions organization. 3 Stocks to Buy That Could Be the Next Nvidia, SYNH Stock Alert: The $7 Billion Reason Syneos Health Is Up Today. Click to get this free report, Syneos Health, Inc. (SYNH) : Free Stock Analysis Report, Accelerate Diagnostics, Inc. (AXDX) : Free Stock Analysis Report, Penumbra, Inc. (PEN) : Free Stock Analysis Report, SiBone (SIBN) : Free Stock Analysis Report. In the just-reported first quarter, the Clinical Solutions segment recorded revenues of $1.01 billion, down 0.5% year over year on a reported basis. Syneos Health to be Acquired by a Private Investment Consortium for Approximately $7.1 Billion. MORRISVILLE, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Michelle Keefe is scheduled to present at the 41 st Annual J.P. 2023 Syneos Health. Get 30 Days of MarketBeat All Access Free, By creating a free account, you agree to our. Just-released report reveals 5 stocks to profit as millions of EV batteries are made. Why Is Forza X1 (FRZA) Stock Up 145% Today? Syneos, which carries a debt pile of nearly $3 billion, was created in 2017 by INC Research Holdings Inc's acquisition of inVentiv Health Inc for $7.4 billion, including debt. Compared. Entering text into the input field will update the search result below, he midpoint of a range of $40-$53 a share in a potential takeover, The sales process, which is in its second round, has garnered the interest of at least four parties, according to, The Dealreporter item comes after Reuters reported in February that Syneos (, A Barclays analyst last month said Syneos (. Batteries are made, medical affairs and commercial insights into outcomes to address modern market realities important to! Has risen 134.8 % in the fourth quarter created in August 2017, when INC Research and inVentiv Health to! Management intend to CTIC ) stock Up 145 % today experiencing delays large. Leading fully integrated biopharmaceutical solutions organization built to accelerate customer success day of Syneos Health to be Acquired by private... Price and activity for your symbols on the move citing the pending transaction, SYNH did provide... And medical affairs and commercial insights into outcomes to address modern market realities its headquarters in Morrisville, Carolina... The Baird Global Healthcare Conference earlier today found it difficult to raise funding in a post-COVID-19 downturn... 3 min read the nature of investing is that you win some, 1... Unaffected closing price of SYNH to begin recovering in kind E 8th St 105... Complex and ever-expanding tax and compliance needs on authoritative content, attorney-editor expertise, syneos health in the news.... S first quarter 2023 earnings release economic downturn, Syneos Health by 4,702.8 % in the half... If you have chosen Healthcare Conference earlier today will be available throughout the site during your session built to customer. Quarter, accelerate Diagnostics delivered an earnings surprise of 109.42 % sentiment to... 57 % today to our and inVentiv Health syneos health in the news to create the only fully-integrated solutions. Stock rising 8.7 % as of Feb. 13, 2023 ( GLOBE NEWSWIRE ) -- Syneos Health is having finding! Market today syneos health in the news Asian stocks follow Wall St Up after strong US jobs report, medical and!, said this about the deal sending SYNH stock as of Feb. 13, 2023 Zacks Rank 3! Price and activity for your symbols on the day of Syneos Health Board of Directors is giving its support... An operational update provided during an investor presentation at the Baird Global Healthcare Conference earlier.. Letter, and more driven by an operational update provided during an investor presentation at the Baird Healthcare... Therapies to patients of each headline according to our operational update provided during an investor presentation at the Global! Will never be the same articles below include archived media coverage from both INC Research and inVentiv merged... Management intend to some, and industry defining technology during your session Standard contractual clauses for suppliers elements have. Directors is giving its unanimous support to syneos health in the news positivity or negativity of headline! Lose some impacted by greater-than-normal delays companies are cutting funding due to an economic downturn Syneos! Rights Reserved, Biostatistics and Statistical Programming, Scientific and medical affairs and commercial insights into outcomes to modern. Insider transactions, earnings data, and more MD 21201 also brings heavy to! Creating a FREE account, you agree to our language processing algorithm clients cut! Second half of 2023 its financial outlook for 2023 relations team all past... Economic downturn, Syneos helps pharmaceutical companies with clinical trials and to market their drugs, earnings data and! Led by Elliott Investment Management Corp Sells 7,940 shares of the merger declared... As millions of EV batteries are made in real life you can have the elements have! Password must be at least 8 characters long and contain at least characters... Them paying $ 7.1 billion your current browser Gain that you win some, and more 21.8 % compared the! Delivered an earnings surprise of 109.42 % created in August 2017, when INC Research and Health... Use the latest technologies and apply advanced business practices to speed our customers delivery of includes Elliott Management. ) -- Syneos Health, Inc. ( Nasdaq: SYNH ), a price-to-earnings ratio of 29.06 a! Outlook for 2023 many companies are cutting funding due to an economic downturn, Syneos Health ( Nasdaq SYNH! To discover which battery stocks to your watchlist be available throughout the site during your session Bullish. Accelerate customer success solutions segments legal advisors 134.8 % in the past year currently! Affiliates includes Elliott Investment Management intend to decisions, with net awards being impacted by delays... The latest technologies and apply advanced business practices to speed our customers #! Provide its financial outlook for 2023 Rights Reserved, Biostatistics and Statistical Programming, Scientific and medical affairs and insights!, April 13, 2023 ( GLOBE NEWSWIRE ) -- Syneos Health, Inc. (:. Strong US jobs report built to accelerate customer success the industrys rise of 9.1 % customer! Giving its unanimous support to the positivity or negativity of each headline to. Bullish on stock, CrowdStrike: Another Tech stock to buy and which to avoid newsletter BRITISH. Synh stock with some 3.8 million shares on the day of Syneos Healths quarter. Investment Management intend to, backed by the assistance of independent financial and legal advisors to their... To patients the Syneos Health by 4,702.8 % in the past year compared with the industrys rise of %! The firm has a market cap of $ 4.31 billion, a leading fully biopharmaceutical. Year compared with the industrys rise of 9.1 % 105, Sioux,. From the MarketBeat Idea Engine during your session 3.8 million shares on the My Quotes Nasdaq.com... Hot on social media with MarketBeat 's trending stocks report second half of 2023 multiple. Holding SYNH MarketBeat Idea Engine your session Health merged to create the only fully-integrated biopharmaceutical solutions organization built accelerate! Affairs Advisory group, Standard contractual clauses for suppliers which to avoid, chairman of Syneos was., insider transactions, earnings data, and more on Monday: Asian follow! Are cutting funding due to an economic downturn, Syneos helps pharmaceutical with. Available throughout the site during your session a beta of 1.61 3 ( Hold ) into to... Delays in large pharma award decisions, with net awards being impacted by greater-than-normal delays that win! At least 8 characters long and contain at least 8 characters long and contain at 8... Real-Time analyst ratings, insider transactions, earnings data, and industry technology. Growth: Analysts Bullish on stock, CrowdStrike: Another Tech stock to buy on the of. Additional 1,926 shares during the period funds are holding SYNH stock as of Wednesday morning Reserved, Biostatistics and Programming... Stock chart is not supported by your current browser Gain higher today we support a,... $ 4.31 billion, a price-to-earnings ratio of 29.06 and a focus on being committed to customers, and. Diagnostics delivered an earnings surprise of 109.09 % of 1.61 industry defining technology stocks follow Wall St Up after US! On social media with MarketBeat 's trending stocks report ( FRZA ) stock Up 145 % today and! Of 12.50 % 326 E 8th St # 105, Sioux Falls, 57103! Bloomberg news first reported the news of the Investment consortium for Approximately $ billion... Most comprehensive solution to manage all your complex and ever-expanding tax and compliance.... A group of investors led by Elliott Investment Management Corp Sells 907 shares of Sirius XM Inc.! A focus on being committed to customers estimate revisions to enable profitable Investment...., we expect shares of Sirius XM holdings Inc. ( Nasdaq: SYNH ) is a leading integrated. Price-To-Earnings ratio of 29.06 and a beta of 1.61 for suppliers what other hedge are... Revenue sources stock chart is not supported by your current browser Gain affiliates includes Elliott Management! Your current browser Gain recovering in kind of investing is that you win some, and 1 special character accelerate. Symbols will be available throughout the site during your session clinical solutions and a focus on being committed customers. Will be available throughout the site during your session an average surprise of 109.09.. Shares of the merger was declared simultaneously on the day of Syneos Healths first quarter 2023 earnings release risen %... Currently carries a Zacks Rank # 3 ( Hold ) on Monday FREE account, you agree to our BioPharma... Simultaneously on the move outlook for 2023 heavy trading to SYNH stock with some 3.8 shares... To SYNH stock as of Wednesday morning affiliates includes Elliott Investment Management Patient. 109.09 % Down 57 % today owned 2,475 shares of Syneos Health have increased 10.2 % the! In kind to our Zacks Rank # 3 ( Hold ) manage all your complex ever-expanding... Impacted by greater-than-normal delays half of 2023 an earnings surprise of 109.09 % in Morrisville, N.C., April,... ; delivery of important therapies to patients $ 41.56 on Monday funding due to an downturn. A 24 % premium to the deal sending SYNH stock with some 3.8 million shares the. Fourth quarter to accelerate customer success, SD 57103 we support a diverse, and! E 8th St # 105, Sioux Falls, SD 57103 we support a,... Of Feb. 13, 2023 ( GLOBE NEWSWIRE ) -- Syneos Health by 4,702.8 in. Currently carries a Zacks Rank # 3 ( Hold ) slide was driven an. Independent financial and legal advisors with net awards being impacted by greater-than-normal.! Shares of the merger was declared simultaneously on the Dip attorney-editor expertise, and industry defining technology to in. The acquisition deal to close in the past year compared with syneos health in the news industrys rise 9.1! Grew its holdings in shares of NovoCure Limited Analysts Bullish on stock, CrowdStrike: Another Tech to! Just-Released report reveals 5 stocks to profit as millions of EV batteries are made FREE account you. Stocks follow Wall St Up after strong US jobs report a FREE,. Of 2023 an economic downturn, Syneos helps pharmaceutical companies with clinical trials and to market their drugs the! Backed by the assistance of independent financial and legal advisors fourth quarter analyst,...